Navigation Links
Accuray Announces Four New Products at Nation's Leading Radiation Oncology Meeting
Date:10/29/2007

ization of products are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward- looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for the fiscal year ended June 30, 2007 and may be updated from time to time by our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.


'/>"/>
SOURCE Accuray Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...a stroke to find that her Geordie accent has gone,...cent//. Lynda Walker, 60, is the victim of a rare... accent. She regained consciousness after a stroke...hat she had lost her strong Geordie twang for a di...
...a more transmissible agent in humans remains high ...us in poultry and the continued exposure to humans.... The overall case-fatality rate was 56 per cent w...0 to 39 years, according to the study by the World...
... half of the women, who received cognitive behavio...attempted for suicide. Women given cognitive beha... than women who were treated by expert therapists ...hor of the study. In addition, the women who rec...
...ondon have developed a new technology that allows ...o the human skeleton// . This is done without any ...y clinical trials as promising. The technique cal...tion Prosthesis (ITAP), works by using a titanium ...
Other Medicine News:Health News:Special Behavioral Therapies made Women more likely to Attempt Suicide 2Health News:Special Behavioral Therapies made Women more likely to Attempt Suicide 3
(Date:10/8/2008)...Potency of Poly-ICR as Vaccine Adjuvant, SAN DIEG...maceuticals,Corporation (TSX: NVN) today presented...proprietary Toll-like Receptor 3 agonist, Poly IC-...gress 2008 in Lyon, France.,Study results demonstr...eting the Toll-like Receptor 3 (TLR3) pathway. Dat...
(Date:10/7/2008)...wswire/ -- Prometheus Laboratories Inc., a,special...s from its,development of PROMETHEUS(R) IBS Diagno...bowel syndrome (IBS). The findings suggest measura...omarkers in blood samples,between IBS and non-IBS ...combined with a proprietary algorithm, led to the ...
(Date:10/7/2008)...- The Texas Cardiac Arrhythmia,Instit...selected as one of,only a few sites in the nation ...or a new device to treat persistent atrial fibrill...and research center specializing in heart,rhythm d...ical Center and,Texas Cardiovascular Consultants.,...
(Date:10/7/2008)...cetate Prevented Immunologic Changes Induced by ...se, Additional Data Indicates Potential in Treatin... 7 /- Alba Therapeutics Corporation,p...ek at the American,College of Gastroenterology (AC... CLIN 1001-004, the first Phase IIa trial conducte...
Breaking Medicine Technology:Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Gene Variant Boosts Risk for Stress Related Ischemia 17446 1Gene Variant Boosts Risk for Stress Related Ischemia 17446 2OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival 17442 1OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival 17442 2Prostate cancer screening program leads to bigger fall in death rates than surrounding areas 17438 1Prostate cancer screening program leads to bigger fall in death rates than surrounding areas 17438 2Prostate cancer screening program leads to bigger fall in death rates than surrounding areas 17438 3UC biology prof traces his roots to the first Earth Day 2992 1UC biology prof traces his roots to the first Earth Day 2992 2UC biology prof traces his roots to the first Earth Day 2992 3
...RE)--Jun 12, 2007 - Inspire,Pharmaceuticals, Inc. ... collaborators related to Inspire will present,inf...emy of,Allergology and Clinical Immunology (EAACI)...d at the 30th European Cystic Fibrosis,Society (EC...k,Turkey., The EAACI Congress includes two presen...
...INESS WIRE)--Jun 11, 2007 - Repros,Therapeutics In...s,from its six month study of Proellex in the trea...urope, enrolled 39,premenopausal women and has com...ree dose levels of Proellex(TM) as well as a,posit...), a GnRH,agonist also known as Lupron(R) or leupr...
Other Medicine Technology:Inspire Announces Presentations at Two European Scientific,Conferences 2Inspire Announces Presentations at Two European Scientific,Conferences 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 2Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 4Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 5Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 6
Rapid Test Kit
The InTray™ GC is a novel device for the growth and detection of both Neisseria gonorrhoeae and Neisseria meningitidis. This product provides a long shelf life and is easily transportable as a
OneStep Strip Style Gonorrhea Test is a rapid direct binding test for the visual detection of gonorrhea antigen, in the secretory specimen and urine from urogenital system, as an aid in the diagnosis
...ser thermal keratoplasty (LTK). This procedure wa...reduction of hyperopia from +0.75 to +2.50 diopter...diopters of astigmatism and refractive stability f...surgery, LTK is not performed in an operating suit...
Medicine Products: